Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.560
-0.040 (-1.54%)
At close: Jun 27, 2025, 4:00 PM
2.600
+0.040 (1.56%)
After-hours: Jun 27, 2025, 7:53 PM EDT

Compass Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
354200199633309-
Upgrade
Market Cap Growth
-3.56%0.34%-68.61%105.02%--
Upgrade
Enterprise Value
2487137516292-
Upgrade
Last Close Price
2.381.451.565.033.17-
Upgrade
PS Ratio
416.47234.71----
Upgrade
PB Ratio
2.981.591.343.492.21-
Upgrade
P/TBV Ratio
3.211.591.343.492.21-
Upgrade
EV/Sales Ratio
291.4783.51----
Upgrade
Debt / Equity Ratio
0.060.050.010.020.030.23
Upgrade
Asset Turnover
0.010.01----
Upgrade
Quick Ratio
7.5614.2819.5411.5413.594.66
Upgrade
Current Ratio
8.3314.9619.7312.0513.844.97
Upgrade
Return on Equity (ROE)
-41.31%-36.07%-25.74%-24.39%-91.30%-115.21%
Upgrade
Return on Assets (ROA)
-26.41%-23.81%-17.66%-14.73%-19.00%-42.25%
Upgrade
Return on Capital (ROIC)
-28.09%-25.09%-18.80%-15.84%-20.21%-45.80%
Upgrade
Earnings Yield
-15.60%-24.75%-21.37%-6.19%-26.60%-
Upgrade
FCF Yield
-12.50%-22.50%-20.44%-5.42%-6.98%-
Upgrade
Buyback Yield / Dilution
-6.33%-8.15%-20.76%-67.31%-104.28%-359.96%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q